-
Three-fold increase in remdesivir production in India: Mansukh Mandaviya
expresspharma
May 07, 2021
Production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021.
-
Eli Lilly accelerates baricitinib’s availability in India
expresspharma
May 07, 2021
Eli Lilly and Company has announced new initiatives to help COVID-19 patients in India as part of its commitment to bring the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world.
-
More than 78 lakh COVID vaccine doses still available with states and UTs: Centre
expresspharma
May 06, 2021
Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 vaccination started on Saturday, it informed.
-
Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India
expresspharma
May 06, 2021
The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days.
-
No more the pharmacy/vaccine maker of the world?
expresspharma
May 06, 2021
In a month’s time, India has gone from exporting COVID-critical medicines and vaccines to requesting stocks from the very nations with whom we have export agreements. There are many reasons for this fall from grace.
-
India to import 4.5 lakh vials of Remdesivir
expresspharma
May 06, 2021
The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country.
-
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
pharmaceutical-technology
May 06, 2021
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country.
-
Gilead Sciences to support expansion of local production capacity of Remdesivir in India
expresspharma
April 28, 2021
Gilead will donate a minimum of 450,000 vials of Veklury to the Government of India.
-
India should step up vaccination rate, enable oxygen supplies to control COVID-19 pandemic: GlobalData
expresspharma
April 27, 2021
A novel ‘double mutant’ variant of SARS-CoV-2, along with other factors, has accelerated the COVID-19 pandemic in India, setting a global record of new daily cases.
-
In discussions with India for vaccine supply: Pfizer
expresspharma
April 23, 2021
A not-for-profit price offered for its vaccine for the government's immunisation programme, informs company.